Literature DB >> 17103235

Role of cysteine 341 and arginine 348 of GLP-1 receptor in G-protein coupling.

Aljosa Bavec1, Yang Jiang, Ulo Langel, Matjaz Zorko.   

Abstract

We have demonstrated the ability of peptides derived from the third intracellular loop of GLP-1 receptor to differently modulate activity of four different types of G-proteins overexpressed in sf9 cells. In this respect, the involvement of Cys(341) in inhibition of G(s) and Cys(341) in activation of G(s) and in inhibition of G(i1,) G(o), and G(11), respectively, indicates their potential role in discrimination between different types of G-proteins. Moreover, these two amino acids from the third intracellular loop might represent an important novel targets for covalent modification by downstream regulators in signaling through GLP-1 receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17103235     DOI: 10.1007/s11033-006-9015-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

1.  Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells.

Authors:  Y F Lin; Y N Jan; L Y Jan
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  Peptitergent PD1 affects the GTPase activity of rat brain cortical membranes.

Authors:  A Bavec; A Juréus; B Cigić; U Langel; M Zorko
Journal:  Peptides       Date:  1999       Impact factor: 3.750

3.  Glucagon-like peptide-1-(7-36)amide increases pulmonary surfactant secretion through a cyclic adenosine 3',5'-monophosphate-dependent protein kinase mechanism in rat type II pneumocytes.

Authors:  E Benito; E Blazquez; M A Bosch
Journal:  Endocrinology       Date:  1998-05       Impact factor: 4.736

4.  Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.

Authors:  P A Frändberg; M Doufexis; S Kapas; V Chhajlani
Journal:  Biochem Biophys Res Commun       Date:  2001-03-09       Impact factor: 3.575

5.  Scanning of the glucagon-like peptide-1 receptor localizes G protein-activating determinants primarily to the N terminus of the third intracellular loop.

Authors:  S K Mathi; Y Chan; X Li; M B Wheeler
Journal:  Mol Endocrinol       Date:  1997-04

6.  Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.

Authors:  J Gromada; W G Ding; S Barg; E Renström; P Rorsman
Journal:  Pflugers Arch       Date:  1997-09       Impact factor: 3.657

7.  Mastoparan-stimulated prolactin secretion in rat pituitary GH3 cells involves activation of Gq/11 proteins.

Authors:  Y Yajima; K Uchino; H Ito; S Kawashima
Journal:  Endocrinology       Date:  1997-05       Impact factor: 4.736

8.  Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.

Authors:  M B Wheeler; M Lu; J S Dillon; X H Leng; C Chen; A E Boyd
Journal:  Endocrinology       Date:  1993-07       Impact factor: 4.736

9.  Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.

Authors:  B Thorens
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

10.  The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system.

Authors:  S Takhar; S Gyomorey; R C Su; S K Mathi; X Li; M B Wheeler
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736

View more
  2 in total

1.  Glucagon like-peptide-1 receptor is covalently modified by endogenous mono-ADP-ribosyltransferase.

Authors:  Matjaž Deželak; Aljoša Bavec
Journal:  Mol Biol Rep       Date:  2011-09-08       Impact factor: 2.316

2.  Functional characterization of N-terminally GFP-tagged GLP-1 receptor.

Authors:  Aljosa Bavec; Alenka Licar
Journal:  J Biomed Biotechnol       Date:  2009-10-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.